Aggregation of Enterovirus Small Plaque Variants and Polioviruses under Low Ionic Strength Conditions

References

1. Agol V. I., Chumakova M. Y. 1962; An agar polysaccharide and d marker of poliovirus. Virology 17:221–223
   [Google Scholar]
2. Balayan M. S., Voroshilova M. K., Sinyak L. I., Chumakova A. B. 1970; Behaviour of poliovirus strains of different virulence under solid overlays. Archiv fur die gesamte Virusforschung 32:299–310
   [Google Scholar]
3. Bachrach H. L., Schwerdt C. E. 1952; Purification studies on Lansing poliomyelitis virus, pH stability, CNS extraction and butanol. Purification experiments. I. Journal of Immunology 69:551–560
   [Google Scholar]
4. Bengtsson S. 1966; Counter-current distribution of poliovirus type 2 and 3. Acta Pathologica et Microbiologica Scandinavica 68:68–80
   [Google Scholar]
5. Bengtsson S., Philipson L., Persson H., Laurent T. C. 1964; The basis for the interaction between attenuated poliovirus and polyions. Virology 24:617–625
   [Google Scholar]
6. Bodian D. 1954; Viremia in experimental poliomyelitis. I. General aspects of infection after intravascular inoculation with strains of high and of low invasiveness. American Journal of Hygiene 60:339–357
   [Google Scholar]
7. Bose H. R., Carl G. Z., Sagik B. P. 1970; Separation of Sindbis virus plaque-type variants by calcium phosphate chromatography. Archiv fur die gesamte Virusforschung 29:83–89
   [Google Scholar]
8. Bottiger M. 1966; Studies on characteristics of poliovirus. I. d marker and temperature. Archiv fur die gesamte Virusforschung 18:119–126
   [Google Scholar]
9. Bresler S., Katsushkina N., Kolikov V., Chumakov M., Pervikov J., Zhdanov S. 1974; Adsorption chromatography of polioviruses on porous glass. Virology 59:36–39
   [Google Scholar]
10. Burness A. T. H. 1967; Separation of plaque-type variants of encephalomyocarditis virus by chromatography on calcium phosphate. Journal of Virology 1:308–316
    [Google Scholar]
11. Cooper P. D. 1969; The genetic analysis of poliovirus. In Biochemistry of Viruses pp 177–218 Edited by Levy H. B. New York: Marcel Dekker;
    [Google Scholar]
12. Cooper P. D., Geissler E., Tannock G. A. 1975; Attempts to extend the genetic map of poliovirus temperature-sensitive mutants. Journal of General Virology 29:109–120
    [Google Scholar]
13. Fiszman M., Bucchini D., Girard M. 1971; Purification of the Sabin strain of poliovirus type 1 through treatment with sarkozyl. Journal of Virology 7:687–689
    [Google Scholar]
14. Furesz J., Armstrong R. E., Moreau P., Nagler F. D. 1964; Genetic markers of poliovirus strains isolated from paralytic patients prior to and after Sabin vaccination programs. II. Studies on type 3 strains. American Journal of Hygiene 80:55–61
    [Google Scholar]
15. Henderson D. A., Witte J. J., Morris L., Langmuir A. D. 1964; Paralytic disease associated with oral poliovaccines. Journal of the American Medical Association 190:153–160
    [Google Scholar]
16. Hodes H. L., Zepp H. D., Ainbender E. 1960; A physical property as a virus marker. Difference in avidity of cellulose resin for virulent (Mahoney) and attenuated (LSc, 2ab) strain of type 1 poliovirus. Virology 11:306–308
    [Google Scholar]
17. Inouye S., Matsuno S., Hasegawa A. 1977; Surface charge of dengue virus hemagglutinins prepared from infected mouse brains. Japanese Journal of Medical Science and Biology 30:109–118
    [Google Scholar]
18. Koza J. 1963; Calcium phosphate adsorption patterns of virulent and avirulent strains of poliovirus. Virology 21:477–481
    [Google Scholar]
19. Lonberg-Holm K. 1975; The effects of concanavalin A on the early events of infection by rhinovirus type 2 and poliovirus type 2. Journal of General Virology 28:313–327
    [Google Scholar]
20. Noble J., Lonberg-Holm K. 1973; Interaction of components of human rhinovirus type 2 with HeLa cells. Virology 51:270–278
    [Google Scholar]
21. Pedersen C. E. Jun, Slocum D. R., Robinson D. M. 1972; Comparative studies of plaque variants derived from a Florida strain of Venezuelan equine encephalomyelitis virus. Infection and Immunity 6:779–784
    [Google Scholar]
22. Philipson L., Beatrice S. T., Crowell R. L. 1973; A structural model of picornaviruses as suggested from an analysis of urea-degraded virions and procapsids of Coxsackievirus B3. Virology 54:69–79
    [Google Scholar]
23. Rueckert R. R., Schafer W. 1965; Studies on the structure of viruses of the Columbia SK group. I. Purification and properties of ME-virus grown in Ehrlich ascites cell suspensions. Virology 26:333–344
    [Google Scholar]
24. Scraba D. G., Hostvedt P., Colter J. S. 1969; Physical and chemical studies of mengo virus variants. II. Chromatographic behaviour and chemical composition. Canadian Journal of Biochemistry 47:165–171
    [Google Scholar]
25. Takemoto K. K. 1966; Plaque mutants of animal viruses. Progress in Medical Virology 8:314–348
    [Google Scholar]
26. Takemoto K. K., Liebhaber H. 1961; Virus-polysaccharide interactions. I. An agar polysaccharide determining plaque morphology of EMC virus. Virology 14:456–462
    [Google Scholar]
27. Takemoto K. K., Liebhaber H. 1962; Virus-polysaccharide interactions. II. Enhancement of plaque formation and the detection of variants of poliovirus with dextran sulfate. Virology 17:499–501
    [Google Scholar]
28. Vogt M., Dulbecco R., Wenner H. A. 1957; Mutants of poliomyelitis virus with reduced efficiency of plating in acid medium and reduced neuropathologenity. Virology 4:141–155
    [Google Scholar]
29. Wallis C., Melnick J. L. 1967; Virus aggregation as the cause of the non-neutralizable persistent fraction. Journal of Virology 1:478–488
    [Google Scholar]
30. Wallis C., Melnick J. L. 1968a; Mechanism of enhancement of virus plaques by cationic polymers. Journal of Virology 2:267–274
    [Google Scholar]
31. Wallis C., Melnick J. L. 1968b; Mechanism of plaque inhibition of poliovirus possessing the d marker. Journal of General Virology 3:349–357
    [Google Scholar]
32. Wallis C., Melnick I. L., Ferry G. D., Wimberly I. L. 1962; An aluminum marker for the differentiation and separation of virulent and attenuated polioviruses. Journal of Experimental Medicine 115:763–775
    [Google Scholar]
33. Who Memorandum 1969; Evidence on the safety and efficacy of live poliomyelitis vaccines currently in use, with special reference to type 3 poliovirus. Bulletin of the World Health Organization 40:925–945
    [Google Scholar]
34. Woods W. A., Robbins F. C. 1961; The elution properties of type 1 polioviruses from Al(OH)₃ gel. A possible attribute. Proceedings of the National Academy of Sciences of the United States of America 47:1501–1507
    [Google Scholar]